ArticleBiomaterials2027
Hydrogel delivery of demineralized bone matrix augmented with ROS-triggered biomineralization and Trb3 activation for enhanced bone regeneration.
Article in Biomaterials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cranial bone defects remain a significant clinical challenge due to limited intrinsic regenerative capacity and an adverse oxidative microenvironment that impairs osteogenesis. Demineralized bone matrix (DBM), a clinically used bone graft substitute, exhibits osteoinductive potential but suffers from inconsistent performance and poor retention at defect sites. Here, we report a DBM-loaded injectable dynamic hydrogel that enhances bone regeneration through coordinated redox modulation, reactive oxygen species (ROS)-triggered biomineralization, and Tribbles homolog 3 (Trb3)-mediated osteogenic signaling. Black phosphorus (BP) nanosheets were functionalized with nuclear localization signal (NLS) peptides through a branched NLS-PEG construct formed by conjugating NLS to multi-armed PEG, followed by electrostatic assembly onto BP nanosheets and subsequent incorporation into a self-healing hydrogel network via dynamic Schiff base crosslinking. The hydrogel effectively scavenges excessive ROS and restores redox balance, while BP degradation releases phosphate to induce ROS-triggered biomineralization and promote a pro-osteogenic microenvironment. In parallel, the BP/NLS system enables gene delivery and nuclear localization of Trb3 plasmid DNA, leading to enhanced Trb3 expression and promotion of BMP/Smad-mediated osteogenic signaling. These combined effects significantly improve the osteoinductive capacity of DBM and promote enhanced bone regeneration in cranial defects. This study provides a strategy to enhance the therapeutic performance of clinically relevant bone graft materials through integrated microenvironment regulation and gene activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.